COVID-19 Vaccine Dosing Interval Studies Advocated By US FDA, ACIP

FDA’s Doran Fink and CDC’s ACIP members say vaccine manufacturers could conduct a study to determine whether longer intervals between doses would provide greater effectiveness and longer durability. Right now, they are relying on international data.